Delivery Order SPE2DB20D3103-SPE2DB23FM3Y1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,809.20 firm-fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division to provide a comprehensive range of medical commodities, including...
- This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,962.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of August 7, 2025. It is not a set-aside contract. AmerisourceBergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the antiviral drug VEKLURY (Remdesivir) in 100 mg vials. The $2,042.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of VEKLURY (remdesivir) 100 mg vials. The firm fixed price contract has a potential value of $27,236.80 and a completion date of March 5, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract has a ceiling value of $6,809.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of VEKLURY 100 mg vials, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a ceiling value of $1,361.84 and a period of performance through May 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,236.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEKLURY 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM3Y1Delivery Order
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This large IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is not designated with any set-aside requirements, indicating open competition. This delivery order is part of the broader pharmaceutical and medical supply procurement efforts by the DLA to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 2/7/23 |